Data / Form D filings / LYZER DIAGNOSTICS INC
LYZER DIAGNOSTICS INC: Form D filing
LYZER DIAGNOSTICS INC, a pharmaceuticals company in Boulder, CO, filed a Form D with the SEC in 2009. The latest, on September 15, 2009, reports $1.3 million sold of a $1.3 million offering to 40 investors.
Find out what LYZER DIAGNOSTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6655 Lookout Road, Suite 120, Boulder, CO, 80301
- Phone
- (303) 527-9904
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2005
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1337540
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 15, 2009 | Amendment | $1,338,000 | $1,338,000 | $0 | 40 | Jan 5, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| STEVEN P. TYRRELL | Executive Officer, Director | |
| PAUL DRAGUL | Director | |
| DONALD WALFORD | Director | |
| DAVID S. WOLFE | Executive Officer, Director | |
| BARRY VANT-HULL | Executive Officer, Director |
Every Form D from the week of Sep 14, 2009 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what LYZER DIAGNOSTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.